Product Images Insulin Glargine U-300
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 51 images provide visual information about the product associated with Insulin Glargine U-300 NDC 0955-3900 by Winthrop U.s, A Business Of Sanofi-aventis U.s. Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - insulin glargine 01
This is a graph that shows the Glucose Infusion Rate (GIR) in mg/(kg*min) over time in hours after a subcutaneous injection. The values are presented on a table and a graph but no additional information is available.*
Image - insulin glargine 02
This text provides a list of body parts: Upper arms, stomach and thighs.*
Image - insulin glargine 03
This appears to be a product manual for a device used for administering doses of insulin. The device features a dose window, dose pointer, dose selector, insulin scale, and an injection button. There is also a pen cap and rubber seal. The manual indicates that the plunger will not be visible until after several doses have been administered.*
Image - insulin glargine 04
Image - insulin glargine 05
Image - insulin glargine 06
Image - insulin glargine 07
Image - insulin glargine 08
Image - insulin glargine 09
Image - insulin glargine 10
Image - insulin glargine 11
Image - insulin glargine 12
Image - insulin glargine 13
Image - insulin glargine 14
Image - insulin glargine 15
Image - insulin glargine 16
Image - insulin glargine 17
Image - insulin glargine 18
Image - insulin glargine 19
Image - insulin glargine 20
Image - insulin glargine 21
Image - insulin glargine 22
Image - insulin glargine 23
Image - insulin glargine 24
Image - insulin glargine 25
Image - insulin glargine 26
This is a list of body parts that includes the upper arms, stomach and thighs.*
Image - insulin glargine 27
The text describes the parts of a cartridge holder used for injecting insulin. It includes a dose window and pointer, dose selector, injection button, pen cap, rubber seal, insulin scale, and insulin name. The plunger is not visible until after some doses have been administered.*
Image - insulin glargine 28
Image - insulin glargine 29
Image - insulin glargine 30
Image - insulin glargine 31
This appears to be a dosage strength specification for a medication, likely intended for subcutaneous injection. The unit "units/mL" is commonly used to measure the concentration of medications such as insulin. Without further context or information about the specific medication, it is difficult to provide more details.*
Image - insulin glargine 32
Image - insulin glargine 33
Image - insulin glargine 34
Image - insulin glargine 35
Image - insulin glargine 36
Image - insulin glargine 37
Image - insulin glargine 38
Image - insulin glargine 39
Image - insulin glargine 40
Image - insulin glargine 41
Image - insulin glargine 42
Image - insulin glargine 43
Image - insulin glargine 44
Image - insulin glargine 45
Image - insulin glargine 46
Image - insulin glargine 47
Image - insulin glargine 48
Image - insulin glargine 49
PRINCIPAL DISPLAY PANEL - 1.5 mL Pen Carton - insulin glargine 50
This is a description of insulin glargine U-300 SoloStar, which is a disposable insulin delivery device intended for subcutaneous use only. The solution is to be used only for single patient use and should not be removed with a syringe. It is advised to mix it gently before use and only use it if clear and colorless with no visible particles. The prefilled pens are to be used within 56 days after opening and needles are not included. The product is manufactured by Winthrop. GTIN number 0030955390035 is also provided.*
PRINCIPAL DISPLAY PANEL - 3 mL Pen Carton - insulin glargine 51
This is a product description and instructions for use of a disposable insulin delivery device called Insulin glargine U-300 Max SoloStar®. The product is Rx only and is only for single patient use. Two 3mL pre-filled pens are dispensed in a sealed carton and needles are not included. The solution should be clear and colorless with no visible particles and should be used within 28 days of opening. The product should not be mixed with other insulins and always use a new needle for administration. The text also includes some product identification numbers.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.